EFG
BMY icon

Embree Financial Group’s Bristol-Myers Squibb BMY Stock Holding History

Embree Financial Group’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$365K Sell
6,342
-340
-5% -$19.5K 0.04% 200
2026
Q1 		$405K Buy
+6,682
New +$390K 0.05% 171
2024
Q2 		– Sell
-9,969
Closed -$541K – 184
2024
Q1 		$541K Sell
9,969
-189
-2% -$9.63K 0.11% 113
2023
Q4 		$521K Buy
+10,158
New +$533K 0.11% 107

Other funds holding BMY

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
ORIO
Old Republic International (ORI) Chicago, Illinois $2.67B AUM 26.94% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
UBP
Union Bancaire Privee Geneva 1, Switzerland $9.16B AUM 31.4% 1-Year Est. Return

Embree Financial Group's BMY Position: Q2 2026 in Review

Embree Financial Group reduced its Bristol-Myers Squibb (BMY) stake by 5.1% in Q2 2026, selling an estimated $19.5K and leaving 6,342 shares worth $365K. The position accounts for 0.04% of the portfolio, ranked #200.

Embree Financial Group first reported a position in BMY in Q4 2023 and has held it in 4 quarters since. The position peaked at $541K in Q1 2024. 440 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Embree Financial Group held 6,342 shares of Bristol-Myers Squibb worth $365K as of Q2 2026.
  • Embree Financial Group sold 340 Bristol-Myers Squibb shares in Q2 2026, an estimated $19.5K.
  • Bristol-Myers Squibb made up 0.04% of Embree Financial Group's portfolio in Q2 2026, its #200 holding.
  • Embree Financial Group first reported a position in Bristol-Myers Squibb in Q4 2023 and has held it in 4 quarters since.
  • Embree Financial Group's Bristol-Myers Squibb position peaked at $541K in Q1 2024.
  • 440 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Embree Financial Group's 13F filing for Q2 2026, filed 15 Jul 2026.